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Abstract
Providing anesthesia for the newborn requires many considerations beyond what is 
needed for the older child or adult. This chapter discusses pertinent anesthetic consider-
ations in the care of surgical neonates including preoperative evaluation, intraoperative 
management and pain management techniques.
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1. Introduction
Advances in pediatric anesthesiology have contributed to improved outcomes and survival 
in newborns requiring surgical intervention. Newborn physiology is characterized by a high 
metabolic rate, limited cardiopulmonary reserve, and decreased renal function. Multisystem 
organ immaturity underlies the differences in physiologic response to anesthetics in the neo-
nate when compared to the older child or adult. This chapter discusses physiologic consider-
ations, preoperative evaluation and preparation, intraoperative anesthetic management, and 
pain management techniques unique to the newborn surgical patient.
2. Physiologic considerations
2.1. Cardiovascular
Fetal cardiac circulation is characterized by two right-to-left shunts: one through the foramen 
ovale and one through the ductus arteriosus. With the infant’s first breaths, the lungs expand, 
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alveolar fluid is cleared, pulmonary vascular resistance markedly decreases, and left atrial 
pressure increases [1]. These physiologic changes promote functional closure of the fetal car-
diac shunts and mark the beginning of the transition from fetal to newborn circulation.
Anatomic closure of the foramen ovale typically occurs within the first year of life, though 
some studies indicate over one quarter of foramen ovale remain echocardiography probe pat-
ent into adulthood [2]. Functional closure of the ductus arteriosus is achieved between 10 and 
15 hours of life, and anatomical closure is usually completed by 2 months of age [3]. Neonatal 
circulation may revert to fetal circulation if the physiological parameters responsible for car-
diac shunt closure are not maintained. As such, it is important to avoid factors that increase 
pulmonary vascular resistance (physiologic stress, hypoxia, hypercarbia, acidosis, and hypo-
thermia) in newborns. Hypervolemia may also promote reopening of the ductus arteriosus 
and should be avoided.
Maintenance of heart rate is essential in the neonatal period. Cardiac output is dependent on 
heart rate, as stroke volume is fixed due to decreased compliance of the immature ventricle 
[4]. Thus, while maintaining preload is important during anesthetic management, increasing 
preload provides minimal benefit for improving cardiac output. The sympathetic nervous 
system is also immature in newborns. Bradycardia may occur after stimulating procedures 
such as laryngoscopy, oropharyngeal suctioning, or gastric tube placement rather than the 
expected tachycardia seen in patients with mature sympathetic nervous systems. Treatment 
with anticholinergics may be required.
2.2. Pulmonary
Development of the respiratory system begins during fetal organogenesis and continues 
throughout childhood. Alveolarization starts at 28 weeks of gestational age, and by 40 weeks, 
alveoli are present at 20–50% of adult values. Type 2 pneumocytes, the main producers of 
surfactant, appear at approximately 24 weeks of gestational age but are not fully functional 
until 34–36 weeks of gestational age [5].
Neonates are an increased risk for respiratory fatigue. High chest wall compliance may cause 
a paradoxical breathing pattern when large breaths are taken [5]. Newborns have a reduced 
number of fatigue-resistant high-oxidative diaphragmatic muscle fibers; mature levels are 
not reached until 8 months of age [6]. Neonatal oxygen requirements are 2–3 times the adult 
requirement, ranging from 6 to 9 mL/kg/min. Increased oxygen demand is met by increased 
respiratory rate, as there is a minimal inspiratory reserve to increase tidal volume [7].
Neonatal respiratory drive is determined by pO
2
 via peripheral chemoreceptors in the carotid 
bodies and by pCO
2
 influencing central chemoreceptors in the medulla. Respiratory drive is 
primarily affected by hypoxia, as opposed to hypercarbia in adults. Administration of high 
oxygen concentrations may depress respiratory drive in the newborn [8].
2.3. Renal
The kidneys are fully developed anatomically by 34–36 weeks of gestational age but continue 
to develop functionally after birth. The glomerular filtration rate (GFR) is initially decreased 
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in the neonate due to low systemic arterial pressure and high renal vascular resistance but 
increases during the first several weeks of extrauterine life [9]. As a result of this initial low 
GFR, there is a decreased ability of the kidneys to maintain electrolyte balance or clear drugs 
and excess fluids.
2.4. Neurologic risk
The neurologic system is anatomically complete at term, though synaptogenesis and nerve 
myelination continue throughout childhood. Data from animal studies, as well as retrospec-
tive human studies, have raised concern that exposure to anesthetic agents could be detri-
mental to cognitive development in young children due to effects either on synaptogenesis or 
apoptosis of the developing brain [10]. The stage of brain development at the time of exposure 
and the degree of anesthetic exposure, in terms of both exposure frequency and cumulative 
anesthetic dose, may affect the risk of neurotoxicity.
The SmartTots program, a partnership between the United States Food and Drug 
Administration and the International Anesthesia Research Society, was established in 2009 to 
address the growing concern regarding potential adverse consequences of general anesthesia 
in young children. Two consensus statements, published in 2012 and 2015, counsel that the 
effect of exposure to anesthetic drugs in young children is unknown. Some, but not all, stud-
ies to date have suggested that problems similar to those seen in animals could also occur in 
infants and toddlers. The benefits of elective procedures must be weighed against the risks 
associated with anesthesia and surgery [11].
3. Preoperative evaluation and preparation
3.1. History and physical examination
A thorough preanesthetic history and physical examination must be performed with the 
goals of identifying potential anesthetic complications due to coexisting disease, determining 
whether further diagnostic studies are required prior to surgery and anticipating postopera-
tive concerns including pain management and level of cardiorespiratory monitoring required.
Factors that should be addressed in the preanesthetic history are outlined in Table 1. A review 
of all organ systems, including identification of genetic syndromes and associated anomalies, 
should be completed. Examination of previous anesthetic and surgical records may reveal 
difficulties with airway management, venous access, or anesthetic emergence and assist in 
planning future anesthetic management.
Physical examination should assess for evidence of coexisting diseases (e.g., craniofacial 
abnormalities, congenital heart disease, chronic lung disease). Hydration status may be deter-
mined by evaluating skin turgor, mucous membranes, fontanelle fullness, and urine output. 
Existing intravenous catheters should be examined for patency and hypovolemia treated 
prior to anesthetic induction. Laboratory studies must be reviewed and significant electrolyte 
abnormalities and/or anemia corrected preoperatively.
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The American Society of Anesthesiologists (ASA) physical status classification system is used as 
a uniform system for describing the degree of patient morbidity prior to an anesthetic (Table 2) 
[12]. The grading system is not intended for use as a measure to predict operative risk.
3.2. Fasting
Infants are required to fast before procedures requiring sedation and anesthesia in order to 
minimize the risk of pulmonary aspiration of gastric contents [13]. Fasting times are based on 
pediatric gastric emptying studies. Table 3 provides a summary of fasting recommendations 
 
Physical score classification* Definition
ASA I A normal healthy patient
ASA II A patient with mild systemic disease
ASA III A patient with severe systemic disease
ASA IV A patient with severe systemic disease that is a constant 
threat to life
ASA V A moribund patient who is not expected to survive without 
the operation
ASA VI A declared brain-dead patient whose organs are being 
removed for donor purposes
*Emergency cases are designated by the addition of “E” to the classification number.
Table 2. American Society of Anesthesiologists physical status classification system.
 
Factor Specific concerns
Maternal history during pregnancy Rh-ABO compatibility
Diabetes
Toxemia
Infection
Drug or alcohol abuse
Gestational age and weight Extreme prematurity and/or extremely low birth weight
Significant birth events Apgar scores
Neonatal asphyxia
Meconium aspiration
Perinatal course Apneas
Supplemental oxygen requirement
Need for ventilator support
Medications and medication allergies Type and severity of adverse medication reaction
Table 1. Factors to address in the preanesthetic history.
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by the ASA [14]. Prolonged fasting may lead to hypovolemia and hypoglycemia in infants; 
glucose-containing intravenous maintenance fluids should be administered prior to the induc-
tion of anesthesia.
The majority of pediatric aspiration events occur during anesthetic induction [15]. Risk 
factors for aspiration in the perianesthetic period include neurologic abnormality, emer-
gency surgery, intestinal obstruction or increased abdominal pressure, light anesthesia, 
and the skill of the anesthesia provider [16, 17]. Infants and young children are particu-
larly prone to regurgitation and aspiration for a variety of reasons including air swallow-
ing while crying and decreased lower esophageal sphincter incompetence. In one study, 
almost all cases of pulmonary aspiration occurred in children who gagged or coughed 
during airway management, either because neuromuscular blockade was not adminis-
tered or airway manipulation occurred before the child was completely paralyzed [15]. 
Mortality due to pulmonary aspiration is low, with an estimated incidence between zero 
and 1:50,000 [15, 16, 18].
3.3. Postoperative apnea in former premature infants
Postoperative apnea is defined as cessation of breathing or no detectable airflow for 15 seconds 
or longer, or less than 15 seconds with bradycardia. It has been observed in former premature 
infants after exposure to all forms of anesthetics (intravenous agents, inhalational agents, and 
regional anesthesia) [19–21]. The incidence of postoperative apnea varies inversely with ges-
tational age at birth and post-conceptual age at the time of surgery. Apnea risk is greater than 
1% until 54 weeks of post-conceptual age or 56 weeks of post-conceptual age in infants with a 
gestational age of 32 or 35 weeks, respectively [22].
Former preterm infants who are less than 60 weeks of post-conceptual age at the time of sur-
gery should be monitored until free of apnea for at least 12 hours. A monitored bed should 
be arranged for the postoperative period, and family members should be educated regard-
ing the risk of perianesthesia apnea. Children receiving theophylline or caffeine preopera-
tively should have these medications continued postoperatively [23]. Caffeine administration 
does not negate the need for postoperative respiratory monitoring. Factors such as anemia, 
hypothermia, hypoglycemia, hypocalcemia, acidosis, and hypoxemia may increase the risk of 
apnea and should be avoided.
 
Ingested material Minimum fasting period (hours)
Clear liquids 2
Breast milk 4
Infant formula 6
Nonhuman milk 6
Light meal 6
Table 3. American Society of Anesthesiologists fasting recommendations.
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4. Intraoperative management
4.1. Monitoring and intravenous access
The ASA’s Standards for Basic Anesthetic Monitoring mandates continual evaluation of 
oxygenation, ventilation, circulation, and temperature during all anesthetics [24]. Placement 
of both a pre-ductal oxygen saturation monitor on the right upper extremity and a post-
ductal oxygen saturation monitor on a lower extremity should be considered in neonates as 
a means to detect right-to-left shunting across the ductus arteriosus [25]. A nerve stimula-
tor may be used if neuromuscular blocking agents are administered, though the train-of-
four response is often diminished in infants less than 2 months old. It is imperative that the 
operating room be kept warm. Neonates, especially premature infants, are at high risk for 
heat loss due to an increased surface area to volume ratio when compared to older children 
and adults [26, 27]. The need for invasive monitoring, including arterial and central venous 
catheter placement, is determined by the baseline medical condition of the patient and the 
extensiveness of the planned surgery. Arterial catheters allow for continuous monitoring of 
heart rate and blood pressure, as well as arterial blood gas sampling [28]. Central venous 
catheters are utilized when large intravenous access is necessary, central venous pressure 
monitoring is required, or in hemodynamically unstable conditions likely to require contin-
uous vasopressor infusions. The benefits of placement must always be weighed against the 
risks associated with use, such as catheter-associated bloodstream infection [29]. A urinary 
catheter should be considered in surgical cases of prolonged duration or when significant 
blood loss is expected.
4.2. Anesthetic agents
Most infants arriving as outpatients for surgery may undergo mask induction of anesthesia 
with inhaled anesthetic agents. Those patients presenting from inpatient hospital wards or 
the neonatal intensive care unit (NICU) with intravenous access in situ may undergo intrave-
nous induction of general anesthesia [27].
4.2.1. Inhaled anesthetic agents
Inhaled halogenated anesthetics (most commonly sevoflurane, isoflurane, and desflurane) are 
used for both induction and maintenance of general anesthesia. The minimum alveolar con-
centration (MAC) is the end-tidal concentration of inhaled anesthetic agent at which 50% of 
patients do not move in response to a noxious stimulus. MAC values are used to compare the 
relative potencies of anesthetic agents and vary with age for each particular agent (Table 4) 
[30–32]. Of note, MAC values may differ for preterm neonates depending upon the inhala-
tional agent used and the gestational age of the infant.
Sevoflurane is the halogenated agent most commonly chosen for mask induction of anes-
thesia; its use is associated with a reduced incidence of breath holding, coughing, laryn-
gospasm, and oxygen desaturation when compared with other inhaled anesthetics [30]. 
Nitrous oxide, a nonhalogenated agent, may be used in conjunction with halogenated 
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inhaled anesthetics to speed inhalational induction (“second-gas effect”) or reduce halo-
genated agent doses during the maintenance phase of anesthesia. Nitrous oxide must be 
used with caution as it may rapidly diffuse into and expand gas-filled body cavities. Its 
use should be avoided in laparoscopic surgery and is contraindicated in patients with a 
pneumothorax [33].
4.2.2. Intravenous anesthetic agents
Similar to inhaled halogenated anesthetics, intravenous anesthetic agents may be utilized for 
both induction and maintenance of anesthesia. Agent choice is commonly based upon the 
following drug properties: speed of onset, duration of action, cardiovascular stability, and 
side-effect profile [34].
Propofol is an intravenous agent with sedative-hypnotic properties resulting from gamma-
aminobutyric acid (GABA)-mediated inhibitory neurotransmission. Systolic blood pressure 
falls approximately 15% after propofol administration due to decreases in preload, cardiac 
contractility, and systemic vascular resistance. Propofol is a potent respiratory depressant, 
and apnea may occur transiently after bolus administration. Pain on injection may be attenu-
ated with intravenous lidocaine administration.
Ketamine is a phencyclidine derivative that antagonizes N-methyl-D-aspartate (NMDA) 
receptors. This results in a “dissociative”-type anesthesia and a potential for disturbing 
dreams or delirium. Ketamine possesses excellent amnestic, analgesic, and bronchodilation 
properties. Administration is associated with favorable hemodynamic parameters except in 
catecholamine-depleted patients. The use is limited in patients with a history of seizure dis-
order and in those in whom increases in intracranial and/or intraocular pressures would be 
detrimental. Nystagmus, myoclonus, and copious oral secretions are frequent side effects of 
ketamine use.
Etomidate depresses the reticular activating system and mimics the inhibitory effects of 
GABA. It possesses minimal effects on the hemodynamic system but can decrease ventila-
tory drive. Induction doses are known to transiently inhibit enzymes involved in cortisol and 
aldosterone synthesis with the potential for adrenocortical suppression.
Thiopental is a barbiturate that acts by prolonging the duration of GABA-mediated chloride 
channel opening. Administration can cause cardiovascular depression that is accentuated in 
the hypovolemic patient. Compared to other induction agents, acute tolerance to thiopental 
may develop, and prolonged sedation can be noted after induction doses [35].
Characteristic Sevoflurane Desflurane Isoflurane Nitrous oxide
MAC adult 2.05% 7.0% 1.2% 104%
MAC neonate (full 
term)
3.2% 9.2% 1.6% –
Table 4. Minimum alveolar concentration (MAC) values for modern inhalational anesthetics.
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4.2.3. Neuromuscular blocking agents
Neuromuscular blocking drugs allow for patient immobility, smooth endotracheal intuba-
tion, increased tolerance of mechanical ventilation, and optimal surgical relaxation. They are 
classified into two groups, depolarizing and non-depolarizing agents, based on activity at the 
neuromuscular junction [36]. The choice of drug depends on the desired speed of onset, dura-
tion of action, route of elimination, and side-effect profile.
Succinylcholine is the only depolarizing agent currently available for clinical use. An increased 
dose of succinylcholine is necessary in infants due to relative effect resistance at the neuro-
muscular junction and the larger volume of distribution in the neonate. Succinylcholine is 
metabolized by circulating pseudocholinesterase. It has a very rapid onset (60 seconds) and 
short duration of action (5 minutes). Succinylcholine carries an FDA “black box warning” 
against routine use in children due to risk of hyperkalemic cardiac arrest in patients with 
undiagnosed neuromuscular disorders [37]. Thus, it is recommended that the use of succi-
nylcholine in children be reserved for emergency intubation or instances where immediate 
securing of the airway is necessary (e.g., laryngospasm, difficulty airway, full stomach) [38].
Non-depolarizing neuromuscular blocking agents are divided into intermediate (atracurium, 
cisatracurium, rocuronium, and vecuronium) and long-acting (pancuronium) varieties [26]. 
Neuromuscular blocking drugs are responsible for over 35% of anesthetic-related hypersensi-
tivity reactions and should be considered as potential causes if anaphylaxis is suspected in the 
perianesthetic period. The effects of non-depolarizing muscle relaxants may be antagonized 
by an anticholinesterase (neostigmine or edrophonium) administered in conjunction with an 
anticholinergic agent (glycopyrrolate or atropine) to minimize parasympathetic side effects. 
Successful reversal of neuromuscular blockade in infants is demonstrated by adequate return 
of strong hip and/or arm flexion, abdominal muscle contraction, and return of the train-of-
four twitch response to four equal twitches.
Historically, neuromuscular blocking drugs could only be reversed after adequate time had 
elapsed to demonstrate some natural return of neuromuscular function. Sugammadex, a 
cyclodextrin oligosaccharide, is a new reversal agent that inactivates steroidal neuromuscular 
blocking agents such as vecuronium and rocuronium via direct encapsulation. This mech-
anism allows for rapid and complete reversal of neuromuscular blockade within minutes 
of administration of a neuromuscular blocking agent. Studies examining sugammadex use 
in children aged 2–18 years suggest no evidence of higher incidence of adverse effects with 
sugammadex compared to that with neostigmine or placebo [39]. Data regarding the safety of 
sugammadex in infants are currently limited.
4.3. Fluid and blood product management
Calculating total intraoperative fluid requirements necessitates considering fluid type, mainte-
nance fluid requirements, evaporative fluid losses, and replacement of intraoperative blood loss.
4.3.1. Glucose requirements
Healthy infants and children can remain euglycemic for up to 17 hours despite fasting. Infants receiv-
ing total parenteral nutrition or 10% dextrose in water (D10W) preoperatively require  continued 
Pediatric and Neonatal Surgery28
glucose replacement intraoperatively [27, 40]. Glucose levels naturally increase intraoperatively 
secondary to decreased insulin sensitivity from release of surgery-related stress hormones.
4.3.2. Maintenance fluid requirements
Maintenance fluid requirements are determined by accounting for water losses from the 
renal, pulmonary, and gastrointestinal systems in addition to calculating baseline body 
weight and calorie usage [40]. While a variety of formulas exist to determine the mainte-
nance fluid requirements of an infant or child, the simplest is the “4-2-1” rule shown in 
Table 5 [40, 41].
D5 0.25% normal saline (NS) and D5 0.45% NS are commonly chosen maintenance fluids for 
children, as they closely accomplish the goal of delivering 3 mEq of sodium, 2 mEq of potas-
sium, 2 mEq of chloride, and 5 g of glucose for every 100 mL of water administered. Nil per os 
(NPO) fluid deficit is calculated by multiplying the hourly maintenance fluid requirement by 
the number of hours the patient has been NPO. The NPO deficit is typically replaced intraop-
eratively as follows: half the total volume deficit is administered in the first hour, one quarter 
in the second hour, and the remaining quarter in the third hour.
Intraoperative evaporative fluid losses may be replenished with isotonic crystalloid or col-
loid fluids according to the following formula based on the invasiveness of surgery: superfi-
cial 1–2 mL/kg/h, moderate/intrathoracic 4–7 mL/kg/h, open intra-abdominal 6–10 mL/kg/h, 
and neonates with necrotizing enterocolitis >50 mL/kg/h. Current data are limited but do not 
support specific benefits of human albumin usage over other colloids or crystalloids in neo-
nates [42, 43]. Favored colloid usage is institutional and region specific; many centers in the 
United States utilize albumin, while institutions in other nations favor hydroxyethyl starches 
or gelatins [44].
4.3.3. Blood products
Estimated blood volume is calculated based on the age and weight of the patient (Table 6) 
[45]. Prior to surgery, one may calculate the maximum allowable blood loss (MABL) that 
would necessitate blood transfusion using the following equation:
   MABL = EBV ×   (Hct current - Hct min)   ____________________________ 
 (Hct current)  (1)
where Hct current is the current hematocrit and Hct min is the minimum acceptable hematocrit.
 
Weight Hourly Day
<10 kg 4 mL/kg 100 mL/kg
10–20 kg 40 mL + 2 mL/kg for every kg >10 kg 1 L + 50 mL/kg for every kg >10 kg
>20 kg 60 mL + 1 mL/kg for every kg >20 kg 1.5 L + 20 mL/kg for every kg >20 kg
Table 5. Maintenance fluid requirements by weight.
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Recommended doses for replacement of blood products are outlined in Table 7 [46].
Packed red blood cells (PRBCs) have a hematocrit of approximately 55–70%. Fresh frozen 
plasma (FFP) administration is indicated when there is laboratory evidence of coagulopathy 
or significant blood loss approaching one blood volume [47]. Intraoperative platelet transfu-
sion is more likely to be necessary with preoperative platelet counts <150,000 per mm3 or 
after the loss of two to three blood volumes [41, 48]. Massive blood loss has historically been 
replaced in a 1:1:1 fashion with PRBCs, FFP, and platelets. Currently, it is recommended that 
FFP administration begins after one blood volume has been lost or at the first sign of clini-
cal coagulopathy [49]. It is imperative for the surgeon and the anesthesiologist to maintain 
excellent communication regarding expectations for blood loss and proper preparation of the 
patient including any necessary laboratory screening tests for blood typing, antibodies, and 
cross matching.
5. Neonatal pain management
Pain has been defined as “an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage” [50]. Accurately 
defining and quantifying pain in the neonate has challenged the medical community for 
decades. Neonatal pain pathways are immature and poorly understood; over 40 different 
pain scales have been developed to assess pain in the term and preterm neonate. Because 
neonates and infants cannot verbally communicate pain, regrettably their pain may go unrec-
ognized and undertreated.
Age Estimated blood volume (mL/kg)
Premature infant (<37 weeks of gestational age) 100
Term infant 90
Toddler 80
School-aged child 75
Adult 65–70
Table 6. Calculating estimated blood volume.
 
Product Dose Expected increase
Packed red blood cells 10–15 mL/kg Hemoglobin 2–3 g/dL
Fresh frozen plasma 10–15 mL/kg Factors 15–25%
Platelets 5–10 mL/kg Platelets 50–100,000/mm3
Cryoprecipitate 1–2 units/kg Fibrinogen 60–100 mg/dL
Table 7. Recommended doses for replacement of blood products.
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Historically, it was believed that neonates did not have the same pain perception as older 
infants and adults. Opioids were known to cause respiratory depression and were consid-
ered harmful; thus, postoperative analgesia with opioids was discouraged. This remained 
the predominant view until as late as in 1987, when research by Anand and colleagues chal-
lenged this long-standing tradition by demonstrating that unattenuated noxious or painful 
stimuli during neonatal cardiac surgery caused a deleterious stress response and increased 
morbidity. Anand published two landmark papers presenting scientific evidence that neo-
nates experience pain and the medical necessity for treating such pain. Change in practice 
soon followed, accompanied by a rapid expansion of literature in this area [51–53].
Neonates in the intensive care unit are estimated to undergo as many as 14 invasive pro-
cedures associated with pain each day, with analgesia inconsistently provided for many of 
these procedures (Table 8) [54]. This is concerning as research has correlated undertreated 
pain in the neonatal period with long-term detrimental effects, including behavioral disorders 
and altered sensitivity to pain later in life [55–59].
5.1. Pain assessment
An ongoing challenge involves appropriately assessing and effectively treating pain in the 
neonate. The immature dorsal horn circuits predominantly exhibit excitatory tone, with 
weaker inhibitory GABA and glycine signaling. It is uncertain whether or not this lack of 
inhibitory processing increases the neonate’s perception of pain. Flexion reflexes may be elic-
ited with either tactile or nociceptive touch; conversely, neonates with no behavioral reaction 
to heel lance showed a strongly activated cortex on EEG in one study, demonstrating the 
inadequacy of behavioral indicators to reliably detect pain [60].
Distinguishing between pain and agitation is also difficult as there are overlapping behav-
ioral and physiologic manifestations [61]. Facial expression (total facial activity with spe-
cific features including brow lowering, eye squeeze, nasolabial furrow, and open mouth) is 
considered the most sensitive behavioral indicator of acute pain. Other behavior pain indi-
cators include body posture, limb movements, cry, consolability, and sleep/wakefulness. 
Physiological parameters include heart rate, respiratory rate and pattern, oxygen saturation, 
 
Diagnostic procedures Arterial puncture, bronchoscopy, endoscopy, heel lancing, 
lumbar puncture, retinopathy of prematurity examination, 
suprapubic bladder tap, venipuncture
Therapeutic procedures Bladder catheterization, central line insertion/removal, 
chest tube insertion/removal, chest physiotherapy, dressing 
change, gavage tube insertion, intramuscular injection, 
peripheral venous catheterization, tracheal tube insertion/
removal, mechanical ventilation, tracheal suctioning, 
postural drainage, adhesive tape removal, ventricular tap
Surgical procedures Circumcision
Other surgical procedures
Table 8. Commonly performed painful procedures in the neonatal intensive care unit.
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and blood pressure. These parameters are also important, but less specific, as alterations may 
be the result of the underlying disease process rather than pain. In the mechanically ventilated 
neonate with neuromuscular blocking therapy, pain must be evaluated based on changes in 
heart rate or blood pressure. Biological markers for pain such as emotional sweating (palm or 
sole, measured by skin conductance or galvanic skin response) or increased stress hormones 
(serum or saliva cortisol) are used in research but have limited clinical utility. Among the vali-
dated neonatal pain scales, premature infant pain profile (PIPP) assesses procedural pain, and 
neonatal pain, agitation, and sedation scale (N-PASS) assesses ongoing pain and sedation in 
both term and preterm neonates, providing an advantage over other available neonatal pain 
assessment tools (Table 9) [62–65].
5.2. Therapeutic approach
Neonatal pain is best managed using a tiered approach. Painful procedures should be avoided 
when possible through the use of noninvasive monitoring and bundling of laboratory blood 
draws. Non-pharmacological therapy, such as nonnutritive sucking, oral sucrose, breast or 
bottle feeding, and swaddling, can be used during mildly painful events (i.e., lab draws, line 
insertion, removal of adhesives, wound treatment, bladder catheterization). Topical anesthet-
ics may be used prior to skin-breaking procedures, though caution must be exercised in the 
preterm neonate as the epidermis is structurally and functionally immature, increasing the 
risk of toxicity. Acetaminophen is effective for mild pain and as an adjuvant for moderate to 
severe pain. Ketamine is a potent analgesic and NMDA antagonist that can be utilized during 
moderate to severe painful procedures of short duration or as an adjuvant to prevent opioid 
tolerance. Systemic opioid analgesics are utilized to treat moderate to severe pain in con-
junction with the above therapies (Table 10) [66, 67]. Analgesic medications are most reliable 
when given intravenously, as oral absorption is unpredictable in the neonate [64, 68].
 
Pain scale Variables included Type of pain assessed
Premature infant pain profile (PIPP) Heart rate, oxygen saturation, facial  
actions
Procedural, postoperative
Neonatal infant pain score (NIPS) Facial expression, crying, breathing 
patterns, arm/leg movement, arousal
Procedural
Neonatal facial coding system (NFCS) Facial actions Procedural
Neonatal pain, agitation, and sedation 
scale (N-PASS)
Crying, irritability, facial expression, 
extremity tone, vital signs
Procedural, postoperative, 
mechanically ventilated patients
Cry, requires oxygen, increased vital 
signs, expression, sleeplessness (CRIES)
Crying, facial expression, sleeplessness, 
requires oxygen to stay at >95% 
saturation, increased vital signs
Postoperative
COMFORT scale Movement, calmness, facial tension, 
alertness, respiration rate, muscle tome, 
heart rate, blood pressure
Postoperative, critical care
Douleur Aigue du Nouveau-ne (DAN) Facial expression, limb movements,  
vocal expression
Procedural
Table 9. Summary of validated neonatal pain scales.
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Postsurgical pain should be anticipated and preemptively treated to mitigate the pain and 
stress response. In conjunction with analgesic medications, local anesthetics may be admin-
istered as a field block, as a targeted nerve block, or as an epidural block (Table 11) to 
effectively treat procedural and surgical pain. Care must be taken during the placement of 
 
Medication Intermittent dose Infusion dose Adverse effects
Acetaminophen 10 mg/kg IV/PO N/A None reported*
NSAIDS Not recommended N/A Unwanted ductal closure, 
gastropathy, nephropathy, 
NEC, IVH, surgical bleeding
Morphine 0.05–0.1 mg/kg IV 0.005–0.03 mg per hour Respiratory depression, 
decreased gastrointestinal 
motility, hypotension, 
urinary retention
Fentanyl 1 mcg/kg IV 0.5–2 mcg/kg per hour Respiratory depression, 
hypotension, muscle rigidity, 
hypothermia
Ketamine 0.5–2 mg/kg IV 0.5–1 mg/kg per hour Respiratory depression, 
increased secretions
NSAIDS, nonsteroidal anti-inflammatory drugs; NEC: necrotizing enterocolitis; IVH: intraventricular hemorrhage
*No reported adverse effects at therapeutic doses. Known hepatotoxicity with overdosing.
Table 10. Recommended analgesic dosing for neonates.
 
Block Indications
Caudal epidural block Lower abdominal surgery, inguinal herniorrhaphy, 
circumcision, orchidopexy, lower limb and pelvic 
orthopedic surgery
Caudal epidural catheter * Lumbar level: lower abdominal, pelvic, and lower limb 
surgery
Thoracic level: upper abdominal, renal, or thoracic surgery
Paravertebral block (via catheter) Unilateral thoracic or renal surgery
Intercostal nerve blocks Thoracic surgery, multiple levels typically required
Brachial plexus block (axillary or infraclavicular) PICC line placement, ischemic limb salvage (arterial 
vasodilation)
Rectus sheath block Umbilical/paraumbilical hernia, laparoscopic surgery, 
pyloromyotomy
Transversus abdominis plane (TAP) block Lower abdominal surgery
Penile block Circumcision
Femoral nerve block PICC line placement lower limbs, muscle biopsy, skin 
graft, clubfoot repair
*Non-tunneled caudal epidural catheters should be removed after 72 hours or sooner when visible signs of soiling are 
present to minimize infectious risks.
Table 11. Neuraxial and peripheral nerve block indications.
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 Local anesthetic toxicity (LAST) management
• Obtain help
• Managing the airway, administering 100% oxygen
• Treat seizure activity (benzodiazepines preferred)
• Alert nearest facility capable of cardiopulmonary bypass
• Support cardiovascular function (prolonged CPR, reduced epinephrine doses)
• Institute 20% lipid emulsion therapy (lipidrescue.org)
Table 13. Treatment of local anesthetic toxicity.
local anesthetics, as unintended intravascular delivery can lead to systemic toxicity man-
ifesting as altered consciousness, seizures, hemodynamic instability, and ultimately car-
diovascular collapse. Safe practice includes aspiration prior to injection, slow incremental 
dosing, adherence to maximum dosing guidelines, and appropriate dose reductions for the 
neonate (Table 12) [69]. Local anesthetic toxicity must be promptly recognized and treated 
(Table 13) [70].
 
Local anesthetic Standard maximum dose * Recommended neonatal 
dose
Comments
Bupivacaine 2.5 mg/kg 1 mg/kg Commonly used for field 
blocks and wound infiltration
Ropivacaine 3 mg/kg 1.5 mg/kg Decreased motor block and 
cardiotoxicity compared with 
bupivacaine
Vasoconstrictor effects (avoid 
using for digital and penile 
blocks)
Lidocaine 5 mg/kg 2.5 mg/kg
Prilocaine Not recommended Not recommended Concern for 
methemoglobinemia
Chloroprocaine 14 mg/kg 7 mg/kg No plasma accumulation due 
to short half life
Topical anesthetic Maximum dose Comments
Eutectic mixture of local 
anesthetics (EMLA)
1 g/5 kg 1 g Equal parts lidocaine and 
prilocaine
Maximum skin contact 
1 hour
Risk of methemoglobinemia 
increased in premature 
neonates
*Maximum doses are additive and not independent of each other; local anesthetic dosing should be decreased by 50% in 
neonates.
Table 12. Commonly used local anesthetics.
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